High dose chemotherapy with autologous bone marrow rescue for children with diffuse pontine brain stem tumors Journal Article
| Authors: | Dunkel, I. J.; Garvin, J. H. Jr; Goldman, S.; Ettinger, L. J.; Kaplan, A. M.; Cairo, M.; Li, H.; Boyett, J. M.; Finlay, J. L.; for the Children’s Cancer Group |
| Article Title: | High dose chemotherapy with autologous bone marrow rescue for children with diffuse pontine brain stem tumors |
| Abstract: | Purpose. Diffuse pontine tumors are highly lethal, and there are few long-term survivors with the standard treatment of external beam irradiation. We investigated the effectiveness of high-dose thiotepa and etoposide-based chemotherapy regimens with autologous bone marrow rescue (ABMR) in children with pontine tumors. Patients and methods. Sixteen children with diffuse pontine tumors were treated. Ten had resistant or recurrent tumors. All ten had previously received irradiation; five had also received chemotherapy and one, beta-interferon. Three high-dose chemotherapy regimens were employed. Six patients received three days of thiotepa (300 mg/m2/day) and etoposide (250-500 mg/m2/day) (TE); two received three days of carmustine (BCNU) (200 mg/m2/day divided every 12 hours) followed by TE (BTE); and two received three days of carboplatin (500 mg/m2/day) followed by TE (CTE). Six other patients had newly-diagnosed tumors and had not received any prior treatment. They all received the BTE regimen and subsequently were treated with hyperfractionated irradiation (7200-7800 cGy) beginning approximately six weeks post-ABMR. Results. There were two toxic deaths (13%), both in previously treated patients, due to multiorgan system failure and Candida septicemia in one case each. Median survival of the patients with resistant or recurrent disease was 4.7 months (range 0.1-18.7) from time of ABMR. Median survival of the newly-diagnosed patients was 11.4 months (range 7.6-17.1) from the time of ABMR. Conclusion. High-dose chemotherapy utilizing these regimens followed by ABMR did not appear to prolong survival compared to conventional therapy in these children with pontine tumors. Alternative strategies need to be developed for this highly lethal disease. |
| Keywords: | adolescent; cancer chemotherapy; cancer survival; child; clinical article; preschool child; school child; child, preschool; survival rate; clinical trial; neutropenia; cancer recurrence; cancer radiotherapy; combined modality therapy; chemotherapy; brain neoplasms; carboplatin; cohort studies; etoposide; mucosa inflammation; antineoplastic combined chemotherapy protocols; carmustine; thiotepa; childhood cancer; survival time; bone marrow transplantation; pons angle tumor; brain stem tumor; beta interferon; brain stem; bone marrow rescue; multiple organ failure; pons; gliomas; autologous bone marrow rescue; humans; human; male; female; article; brain stem tumors |
| Journal Title: | Journal of Neuro-Oncology |
| Volume: | 37 |
| Issue: | 1 |
| ISSN: | 0167-594X |
| Publisher: | Springer |
| Date Published: | 1998-03-01 |
| Start Page: | 67 |
| End Page: | 73 |
| Language: | English |
| DOI: | 10.1023/a:1005874508975 |
| PUBMED: | 9525840 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | Article -- Export Date: 12 December 2016 -- Source: Scopus |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work